Koninklijke Philips N.v (PHG)

$25.97

+0.04

(+0.15%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $25.96
    $26.16
    $25.97
    downward going graph

    0.06%

    Downside

    Day's Volatility :0.76%

    Upside

    0.71%

    downward going graph
  • $17.16
    $28.47
    $25.97
    downward going graph

    33.92%

    Downside

    52 Weeks Volatility :39.73%

    Upside

    8.78%

    downward going graph

Returns

PeriodKoninklijke Philips N.v
3 Months
27.88%
6 Months
17.41%
1 Year
20.55%
3 Years
-41.55%

Highlights

Market Capitalization
24.3B
Book Value
$13.16
Earnings Per Share (EPS)
-0.9
PEG Ratio
2.81
Wall Street Target Price
27.14
Profit Margin
-4.41%
Operating Margin TTM
-19.89%
Return On Assets TTM
0.87%
Return On Equity TTM
-3.58%
Revenue TTM
18.1B
Revenue Per Share TTM
19.68
Quarterly Revenue Growth YOY
-0.7000000000000001%
Gross Profit TTM
7.2B
EBITDA
876.0M
Diluted Eps TTM
-0.9
Quarterly Earnings Growth YOY
-0.72
EPS Estimate Current Year
1.51
EPS Estimate Next Year
1.73
EPS Estimate Current Quarter
0.28
EPS Estimate Next Quarter
0.33

Analyst Recommendation

Hold
    37%Buy
    55%Hold
    7%Sell
Based on 27 Wall street analysts offering stock ratings for Koninklijke Philips N.v(by analysts ranked 0 to 5 stars)
Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
4
4
Hold
15
12
13
Sell
2
13
12

Analyst Forecast

What analysts predicted

Upside of 4.51%

Current $25.97
Target $27.14

Company Financials

FY18Y/Y Change
Revenue
20.7B
↑ 1.92%
Net Income
1.2B
↓ 34.22%
Net Profit Margin
6.02%
↓ 3.3%
FY19Y/Y Change
Revenue
21.8B
↑ 7.51%
Net Income
1.3B
↑ 7.16%
Net Profit Margin
6.0%
↓ 0.02%
FY20Y/Y Change
Revenue
24.0B
↑ 0.27%
Net Income
1.5B
↑ 1.63%
Net Profit Margin
6.08%
↑ 0.08%
FY21Y/Y Change
Revenue
19.4B
↓ 12.18%
Net Income
693.1M
↓ 48.44%
Net Profit Margin
3.57%
↓ 2.51%
FY22Y/Y Change
Revenue
19.1B
↑ 3.91%
Net Income
-1.7B
↓ 364.38%
Net Profit Margin
-9.08%
↓ 12.65%
FY23Y/Y Change
Revenue
18.2B
↑ 1.92%
Net Income
-466.0M
↓ 71.2%
Net Profit Margin
-2.56%
↑ 6.52%
Q4 FY22Q/Q Change
Revenue
5.8B
↑ 25.8%
Net Income
-121.0M
↓ 91.5%
Net Profit Margin
-2.08%
↑ 28.76%
Q1 FY23Q/Q Change
Revenue
4.5B
↓ 23.15%
Net Income
-723.0M
↑ 486.73%
Net Profit Margin
-15.91%
↓ 13.83%
Q2 FY23Q/Q Change
Revenue
4.9B
↑ 7.27%
Net Income
78.6M
↓ 110.86%
Net Profit Margin
1.61%
↑ 17.52%
Q3 FY23Q/Q Change
Revenue
4.5B
↑ 0.02%
Net Income
88.0M
↑ 22.22%
Net Profit Margin
1.97%
↑ 0.36%
Q4 FY23Q/Q Change
Revenue
5.1B
↑ 13.22%
Net Income
39.0M
↓ 55.68%
Net Profit Margin
0.77%
↓ 1.2%
Q1 FY24Q/Q Change
Revenue
4.5B
↓ 18.25%
Net Income
-1.1B
↓ 2661.54%
Net Profit Margin
-24.14%
↓ 24.91%
FY18Y/Y Change
Total Assets
29.8B
↑ 2.78%
Total Liabilities
15.9B
↑ 4.59%
FY19Y/Y Change
Total Assets
30.2B
↑ 3.7%
Total Liabilities
16.1B
↑ 3.28%
FY20Y/Y Change
Total Assets
34.1B
↑ 2.71%
Total Liabilities
19.4B
↑ 10.13%
FY21Y/Y Change
Total Assets
35.1B
↑ 11.72%
Total Liabilities
18.7B
↑ 4.27%
FY22Y/Y Change
Total Assets
32.9B
↓ 0.88%
Total Liabilities
18.6B
↑ 5.57%
FY23Y/Y Change
Total Assets
29.4B
↓ 4.18%
Total Liabilities
17.3B
↓ 0.34%
Q4 FY22Q/Q Change
Total Assets
32.9B
↓ 5.55%
Total Liabilities
18.6B
-
Q1 FY23Q/Q Change
Total Assets
33.5B
↑ 0.0%
Total Liabilities
17.8B
↓ 6.06%
Q2 FY23Q/Q Change
Total Assets
32.2B
↓ 3.85%
Total Liabilities
18.9B
↑ 6.09%
Q4 FY23Q/Q Change
Total Assets
29.4B
↓ 0.34%
Total Liabilities
17.3B
-
FY18Y/Y Change
Operating Cash Flow
2.0B
↓ 4.81%
Investing Cash Flow
-1.7B
↓ 53.55%
Financing Cash Flow
-1.4B
↓ 2267.27%
FY19Y/Y Change
Operating Cash Flow
2.3B
↑ 14.1%
Investing Cash Flow
-675.5M
↓ 59.42%
Financing Cash Flow
-1.9B
↑ 39.68%
FY20Y/Y Change
Operating Cash Flow
3.4B
↑ 36.73%
Investing Cash Flow
-1.6B
↑ 118.24%
Financing Cash Flow
594.1M
↓ 129.01%
FY21Y/Y Change
Operating Cash Flow
1.8B
↓ 41.34%
Investing Cash Flow
-4.2B
↑ 179.03%
Financing Cash Flow
-2.7B
↓ 585.92%
FY22Y/Y Change
Operating Cash Flow
-185.3M
↓ 110.62%
Investing Cash Flow
-1.6B
↓ 59.5%
Financing Cash Flow
535.6M
↓ 121.3%
Q4 FY20Q/Q Change
Operating Cash Flow
3.3B
↑ 284.14%
Investing Cash Flow
-1.6B
↑ 131.69%
Financing Cash Flow
594.1M
↓ 35.69%
Q2 FY21Q/Q Change
Operating Cash Flow
901.1M
↓ 71.74%
Investing Cash Flow
-3.8B
↑ 143.69%
Financing Cash Flow
238.3M
↓ 58.39%
Q4 FY21Q/Q Change
Operating Cash Flow
5.7B
↑ 562.11%
Investing Cash Flow
-4.2B
↑ 14.5%
Financing Cash Flow
-2.7B
↓ 1267.66%
Q2 FY22Q/Q Change
Operating Cash Flow
-617.4M
↓ 111.74%
Investing Cash Flow
-916.2M
↓ 76.12%
Financing Cash Flow
364.6M
↓ 114.87%
Q4 FY22Q/Q Change
Operating Cash Flow
111.4M
↓ 117.6%
Investing Cash Flow
-1.6B
↑ 69.56%
Financing Cash Flow
535.6M
↑ 43.27%
Q2 FY23Q/Q Change
Operating Cash Flow
392.8M
↑ 246.15%
Investing Cash Flow
-391.7M
↓ 75.86%
Financing Cash Flow
-183.3M
↓ 133.6%

Technicals Summary

Sell

Neutral

Buy

Koninklijke Philips N.v is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Koninklijke Philips N.v
Koninklijke Philips N.v
-0.99%
17.41%
20.55%
-41.55%
-41.3%
Stryker Corporation
Stryker Corporation
0.78%
11.04%
17.54%
29.67%
60.01%
Boston Scientific Corp.
Boston Scientific Corp.
2.45%
31.16%
50.64%
78.74%
83.32%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-3.46%
20.0%
-4.76%
-20.06%
21.53%
Abbott Laboratories
Abbott Laboratories
-1.31%
-6.18%
-9.34%
-13.05%
17.3%
Medtronic Plc
Medtronic Plc
-2.02%
-6.28%
-10.55%
-38.0%
-22.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Koninklijke Philips N.v
Koninklijke Philips N.v
75.3
NA
2.81
1.51
-0.04
0.01
NA
13.16
Stryker Corporation
Stryker Corporation
39.04
39.04
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
65.18
65.18
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.93
37.93
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.72
32.72
5.99
4.65
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
28.73
28.73
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Koninklijke Philips N.v
Koninklijke Philips N.v
Hold
$24.3B
-41.3%
75.3
-4.41%
Stryker Corporation
Stryker Corporation
Buy
$130.4B
60.01%
39.04
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$114.0B
83.32%
65.18
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$53.0B
21.53%
37.93
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$180.4B
17.3%
32.72
13.65%
Medtronic Plc
Medtronic Plc
Buy
$101.7B
-22.41%
28.73
11.36%

Institutional Holdings

  • Mondrian Investment Partners Ltd

    1.02%
  • Fiduciary Management, Inc. of Milwaukee

    0.73%
  • FMR Inc

    0.61%
  • BlackRock Inc

    0.60%
  • Morgan Stanley - Brokerage Accounts

    0.34%
  • Dimensional Fund Advisors, Inc.

    0.34%

Corporate Announcements

  • Koninklijke Philips N.v Dividends September,2022

    In the quarter ending September,2022. Koninklijke Philips N.v has declared dividend of $0.91

    Read More

Company Information

Koninklijke Philips N.V., commonly shortened to Philips, is a Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891. Since 1997, it has been mostly headquartered in Amsterdam, though the Benelux headquarters is still in Eindhoven.

Organization
Koninklijke Philips N.v
Employees
69062
CEO
Mr. Roy Jakobs
Industry
Electronic Technology

FAQs